112 related articles for article (PubMed ID: 10168544)
1. Modification of activation-dependent platelet antigens CD62p and CD63 during haemodialysis.
Gutensohn K; Sputtek A; Voss A; Stahl RA; Kuehnl P
Transfus Sci; 1996 Dec; 17(4):489-92. PubMed ID: 10168544
[TBL] [Abstract][Full Text] [Related]
2. Platelet surface CD62P and CD63, mean platelet volume, and soluble/platelet P-selectin as indexes of platelet function in atrial fibrillation: a comparison of "healthy control subjects" and "disease control subjects" in sinus rhythm.
Choudhury A; Chung I; Blann AD; Lip GY
J Am Coll Cardiol; 2007 May; 49(19):1957-64. PubMed ID: 17498581
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation during haemodialysis: comparison of cuprammonium rayon and polysulfone membranes.
Thijs A; Grooteman MP; Zweegman S; Nubé MJ; Huijgens PC; Stehouwer CD
Blood Purif; 2007; 25(5-6):389-94. PubMed ID: 17890860
[TBL] [Abstract][Full Text] [Related]
4. [Flow-cytometric analysis of platelet activation during rotablation].
Bau J; Gutensohn K; Kuck KH; Beythien C; Stein J; Kühnl P
Z Kardiol; 2000 Jan; 89(1):15-20. PubMed ID: 10663912
[TBL] [Abstract][Full Text] [Related]
5. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
McKenzie ME; Malinin AI; Bell CR; Dzhanashvili A; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):249-53. PubMed ID: 12695747
[TBL] [Abstract][Full Text] [Related]
6. Mild-to-moderate renal impairment is associated with platelet activation: a cross-sectional study.
Thijs A; Nanayakkara PW; Ter Wee PM; Huijgens PC; van Guldener C; Stehouwer CD
Clin Nephrol; 2008 Oct; 70(4):325-31. PubMed ID: 18826858
[TBL] [Abstract][Full Text] [Related]
7. [Detection of platelet activation by flow cytometry in patients with pre-eclampsia].
Yi ZS; Zhou SY; Meng FY; Feng R; Liu QF; Lin R
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1095-6. PubMed ID: 14559705
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric analysis of platelet membrane antigens during and after continuous-flow plateletpheresis.
Gutensohn K; Bartsch N; Kuehnl P
Transfusion; 1997 Aug; 37(8):809-15. PubMed ID: 9280325
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation in clinical haemodialysis: LMWH as a major contributor to bio-incompatibility?
Gritters M; Borgdorff P; Grooteman MP; Schoorl M; Schoorl M; Bartels PC; Tangelder GJ; Nubé MJ
Nephrol Dial Transplant; 2008 Sep; 23(9):2911-7. PubMed ID: 18364368
[TBL] [Abstract][Full Text] [Related]
10. Levels and value of platelet activation markers in different subtypes of acute non-cardio-embolic ischemic stroke.
Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Wang HC; Lee TH; Lu CH
Thromb Res; 2009 Jun; 124(2):213-8. PubMed ID: 19233449
[TBL] [Abstract][Full Text] [Related]
11. Alteration of platelet-associated membrane glycoproteins during extracorporeal apheresis of peripheral blood progenitor cells.
Gutensohn K; Maerz M; Kuehnl P
J Hematother; 1997 Aug; 6(4):315-21. PubMed ID: 9377070
[TBL] [Abstract][Full Text] [Related]
12. [Detection of platelet activation].
Matsuno K
Rinsho Byori; 1995 May; 43(5):432-7. PubMed ID: 7540228
[TBL] [Abstract][Full Text] [Related]
13. Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure.
Chung I; Choudhury A; Patel J; Lip GY
Ann Med; 2009; 41(1):45-51. PubMed ID: 18618353
[TBL] [Abstract][Full Text] [Related]
14. Significance of membrane glycoproteins in platelet interaction with oxidized low-density lipoprotein.
Takahashi Y; Fuda H; Yanai H; Akita H; Shuping H; Chiba H; Matsuno K
Semin Thromb Hemost; 1998; 24(3):251-3. PubMed ID: 9701456
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the extent of platelet activation in platelet concentrates and in vitro and in vivo parameters.
Dijkstra-Tiekstra MJ; Pietersz RN; Huijgens PC
Vox Sang; 2004 Nov; 87(4):257-63. PubMed ID: 15585021
[TBL] [Abstract][Full Text] [Related]
16. Tantalum stents induce expression of GMP140 and GP53 on platelets after contact in an in vitro model.
Gutensohn K; Beythien C; Bau J; Meinertz T; Kühnl P
Beitr Infusionsther Transfusionsmed; 1996; 33():61-5. PubMed ID: 8865937
[TBL] [Abstract][Full Text] [Related]
17. Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets.
Tschoepe D; Spangenberg P; Esser J; Schwippert B; Kehrel B; Roesen P; Gries FA
Cytometry; 1990; 11(5):652-6. PubMed ID: 1696196
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of desflurane and sevoflurane on the expression of platelet surface glycoproteins in unstimulated and adenosine diphosphate-induced platelets in vitro.
Koroglu A; Cicek M; Toprak HI; Karakoc Y; Noyan F; Ersoy OM
J Clin Anesth; 2007 Aug; 19(5):328-33. PubMed ID: 17869981
[TBL] [Abstract][Full Text] [Related]
19. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
[TBL] [Abstract][Full Text] [Related]
20. A P-selectin/CD62P monoclonal antibody (LYP-20), in tandem with flow cytometry, detects in vivo activated circulating rat platelets in severe vascular trauma.
Chignier E; Parise M; McGregor L; Delabre C; Faucompret S; McGregor J
Thromb Haemost; 1994 Nov; 72(5):745-9. PubMed ID: 7534947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
